Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNITION THERAPEUTICS INCCGTX · Entity 6792 | Chief Medical Officer | April 16, 2026 | April 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNITION THERAPEUTICS INC
Report date April 16, 2026 · Filed April 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 874,906 |
Reported balance
After 2026-04-16 transaction · row 1
1 source rowRow 1 · 2026-04-16 · Purchase · Acquired 10,000 · Balance 874,906 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2026 Filed Apr 20, 2026 20:15 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | PurchaseCommon Stock | 10,000 | $1.11 | $11,100.00 |
DisclosureSEC source: 0001104659-26-045499 · tm2612247-1_4seq1.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 874,906 Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:15 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 4,680 | $1.12 | $5,241.60 |
DisclosureSEC source: 0001104659-26-017063 · tm266602-1_4seq1.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 864,906 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 22:26 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 26,919 | $1.03 | $27,726.57 |
DisclosureSEC source: 0001104659-26-011073 · tm265419-1_4seq1.xml · nonDerivative · entry 3 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869,586 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 22:26 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 11,488 | $1.12 | $12,866.56 |
DisclosureSEC source: 0001104659-26-011073 · tm265419-1_4seq1.xml · nonDerivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,505 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 22:26 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-011073 · tm265419-1_4seq1.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 907,993 F1 · kind: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 21:10 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 20,280 | $1.50 | $30,420.00 |
DisclosureSEC source: 0001104659-25-123722 · tm2534021-2_4seq1.xml · nonDerivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,993 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 21:10 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-123722 · tm2534021-2_4seq1.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,273 F1 · kind: Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 20:24 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 20,281 | $0.67 | $13,592.33 |
DisclosureSEC source: 0001062993-25-013358 · form4.xml · nonDerivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,273 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 20:24 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-013358 · form4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,554 F1 · kind: Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025. Read SEC document |
| February 15, 2025 Filed Feb 18, 2025 21:28 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 5,296 | $0.59 | $3,125.17 |
DisclosureSEC source: 0001062993-25-002704 · form4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,554 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 04, 2025 Filed Feb 4, 2025 21:13 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 295,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001622 · form4.xml · nonDerivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,850 F2 · kind: Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:13 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 12,779 | $0.67 | $8,510.81 |
DisclosureSEC source: 0001062993-25-001622 · form4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,850 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:13 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001062993-24-003649 · form4.xml · derivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-02-15 F2 · derivative.exercise_date: The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:13 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003649 · form4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,629 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| February 03, 2024 Filed Feb 10, 2024 00:12 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | Tax withholdingCommon Stock | 12,777 | $2.29 | $29,259.33 |
DisclosureSEC source: 0001062993-24-002775 · form4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,629 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:05 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (Right to Buy) · Derivative | 94,406 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0000899243-23-004184 · doc4.xml · derivative · entry 2 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,406 Underlying: Common Stock · 94,406 shares Expires 2033-02-03 F2 · derivative.exercise_date: The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:05 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 94,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004184 · doc4.xml · nonDerivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,406 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 23:01 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.05 | $0.00 |
DisclosureSEC source: 0001062993-22-008680 · form4.xml · derivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-03-23 F1 · derivative.exercise_date: The option vests 25% on March 23, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer on such vesting date. Read SEC document |
| November 01, 2021 Filed Nov 10, 2021 22:57 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (right to buy) · Derivative | 161,676 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001891015-21-000016 · edgar.xml · derivative · entry 1 Caggiano Anthony · CIK 0001892981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,676 Underlying: Common Stock · 161,676 shares Expires 2031-11-01 F1 · derivative.exercise_date: 25% of the shares of common stock underlying the option vest on November 1, 2022. The remaining shares underlying the option will vest and become exercisable thereafter in equal installments every six (6) months until November 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.